Melanoma Clinical Trials in Houston

Showing 261-280 of 307 trials

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

NCT00563290

This phase II trial is studying how well dasatinib works in treating patients with unresectable or metastatic squamous cell skin cancer or RAI Stage 0-I chronic lymphocytic leukemia. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recurrent Skin CancerSquamous Cell Carcinoma of the SkinStage 0 Chronic Lymphocytic Leukemia+1 more

National Cancer Institute (NCI)7 participantsStarted Nov 2007

Cincinnati, Ohio, United States • Columbus, Ohio, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

NCT00005057

RATIONALE: Inserting a modified herpesvirus gene into a person's melanoma cells may make the cancer more sensitive to the antiviral agent ganciclovir. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have stage IV melanoma.

Melanoma (Skin)

National Human Genome Research Institute (NHGRI)Started Mar 2000

Bethesda, Maryland, United States • Bethesda, Maryland, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

NCT00089193

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Colony-stimulating factors such as sargramostim may increase the number of immune cells found in bone marrow or peripheral blood. Combining vaccine therapy with sargramostim may cause a stronger immune response and kill more tumor cells. PURPOSE: This randomized phase II trial is studying vaccine therapy and sargramostim to see how well they work compared to vaccine therapy alone in treating patients with stage II B, stage IIC, stage III, or stage IV melanoma.

Melanoma (Skin)

Craig L Slingluff, JrStarted Sep 2003

Washington D.C., District of Columbia, United States • Philadelphia, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States +2 more locations

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Melanoma Trials in Other Cities

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Vaccine Therapy in Treating Patients With Malignant Melanoma

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

A Phase I/II Study of Dasatinib and Dacarbazine

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Other Conditions in Houston